![Bob Kanuga](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bob Kanuga
Corporate Officer/Principal bei Ajinomoto Bio-Pharma Services
Aktive Positionen von Bob Kanuga
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ajinomoto Bio-Pharma Services
![]() Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Bob Kanuga
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Ajinomoto Bio-Pharma Services
![]() Ajinomoto Bio-Pharma Services BiotechnologyHealth Technology Ajinomoto Bio-Pharma Services provides clinical and commercial product development, manufacturing and fill finish services. It offers platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing. The company was founded in 2018 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Bob Kanuga
- Erfahrung